Editor(s):

(1) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

Reviewers:

(1) Naeem Hasan Khan, AIMST University, Malaysia.

(2) Apostolia Tsiasioti, Aristotle University of Thessaloniki, Greece.

Additional Reviewers:

(1) Saddam Nawaz, Bangladesh.

(2) Worathat Thitikornpong, Chulalongkorn University, Thailand.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.5/10

Average Peer review marks at publication stage: 9/10

Peer Review History:

---

Stage 1 | Original Manuscript | File 1 | NA

---

Stage 2 | Peer review report_1 (Naeem Hasan Khan, Malaysia) | File 1 | NA

---

Stage 2 | Peer review report_2 (Apostolia Tsiasioti, Greece) | File 1 | NA

---

Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2

---

Stage 3 | Comment_Editor_1_v1 | File 1 | NA

---